A. Cosedimentation assay to quantitatively examine the
binding affinity of Kif7DM-GFP (1 μM) to GDP-taxol stabilized
microtubules (0–5 μM) in the presence of 1 mM ATP (black) ADP
(purple) and AMPPNP (blue). Error bars represent standard deviation. The plots
of fraction of Kif7DM-GFP bound versus microtubule concentration were
fit to a Hill equation to determine the equilibrium dissociation constants under
different nucleotide conditions. (Kd for Kif7DM-GFP, ATP:
0.78 ± 0.10 μM, ADP: 0.81 ± 0.16 μM and AMPPNP: 0.43
± 0.03 μM).
B. Representative images showing Kif7DM-GFP
(150 nM) associated with segmented microtubules composed of the GMPCPP-seed
(red), GDP growth (blue) and GMPCPP+GDP cap (red) in the presence of different
adenosine nucleotides (1 mM ATP, ADP, AMPPNP and ATPγS). The schematics
under the images indicate the position of the seed (brown), growth (blue), cap
(red) and the associated Kif7DM-GFP signal (green).
C. Scatter plot of GFP fluorescence intensity per pixel of
microtubule-bound Kif7DM-GFP (150 nM) on the indicated microtubule
segments. Error bars represent standard deviation. Assay conditions: 150 nM
Kif7DM-GFP and 1 mM ATP (black), ADP (purple), AMPPNP (blue),
ATPγS (green) on the GMPCPP-seed, GTP►GDP growth and GMPCPP+GDP
cap. (GMPCPP-Seed: ATP: 202.3 ± 61.7; N = 93, ADP: 53.0 ± 14.0; N
= 65, AMPPNP: 693.4 ± 141.7; N = 93 and ATPγS: 591.5 ±
172.7; N = 68. GDP growth: ATP: 14.1 ± 9.3; N = 93, ADP: 8.6 ±
5.4; N = 65, AMPPNP: 216.5 ± 96.5; N = 93 and ATPγS: 207.6
± 102.9; N = 68. GMPCPP+GDP cap: 80.8 ± 47.0; N = 93, ADP: 37.1
± 15.8; N = 65, AMPPNP: 401.2 ± 203.5; N = 93 and ATPγS:
338.2 ± 165.7; N = 68).
D. Scatter plot of the intensity ratio of
microtubule-bound Kif7DM-GFP on the GMPCPP-seed and GTP►GDP
growth regions in the presence of different adenosine nucleotides. Error bars
represent standard deviation. Assays were performed under Kif7DM-GFP
concentrations that resulted in similar average fluorescence intensities on the
GMPCPP-seed in the presence of different nucleotides to allow for normalization.
Assay conditions: 150 nM Kif7DM-GFP and 1 mM ATP; 250 nM
Kif7DM-GFP and 1 mM ADP; 10 nM Kif7DM-GFP and 1 mM
AMPPNP; 50 nM Kif7DM-GFP and 1 mM ATPγS. (GMPCPP/GDP: ATP:
10.53 ± 6.04; N = 62, ADP: 8.19 ± 3.84; N = 68, AMPPNP: 2.51
± 0.96; N = 78 and ATPγS: 3.32 ± 1.71; N = 61).
E. Biolayer interferometry assay to quantitatively examine
the binding affinity of Kif7DM to soluble tubulin (0–20
μM) in the presence of 1 mM ATPγS (green) and AMPPNP (blue). Error
bars represent standard deviation. The plots of fraction of Kif7DM
bound versus soluble tubulin concentration were fit to a Hill equation to
determine the equilibrium dissociation constants under different nucleotide
conditions. (Kd for Kif7DM, ATPγS: 4.98 ±
0.9 μM and AMPPNP: 1.64 ± 0.2 μM).